Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase cervical cancer risk and affect its development.

The guidelines standardize mesotherapy practices for safety and effectiveness in pain, rehabilitation, and skin treatments.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Shi-Bi-Man, a Traditional Chinese Medicine, helps grow hair by boosting lactic acid metabolism and activating hair follicle stem cells.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 affects multiple body systems, not just the lungs.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 can cause skin changes, possibly from the virus, drugs, or lifestyle changes.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

AGA linked to worse COVID-19 outcomes in men.

Testosterone may influence COVID-19 severity and outcomes.